Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ClearPoint Neuro Inc. - Common Stock (NQ:CLPT)

12.40 -2.98 (-19.37%)
Streaming Delayed Price Updated: 10:06 AM EDT, Aug 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 901,015
Open 13.02
Bid (Size) 12.40 (100)
Ask (Size) 12.43 (200)
Prev. Close 15.38
Today's Range 12.27 - 13.39
52wk Range 8.270 - 30.10
Shares Outstanding 23,639,616
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ClearPoint Neuro Q2 Earnings Call Highlights ↗
ClearPoint Neuro (NASDAQ:CLPT) reported second-quarter 2026 revenue growth while outlining a shift in investment priorities toward clinical capacity, preclinical laboratory services and technologies... 
Via MarketBeat
Topics Earnings
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill

Performance

YTD
-11.6%
-11.6%
1 Month
-31.1%
-31.1%
3 Month
+10.9%
+10.9%
6 Month
-6.3%
-6.3%
1 Year
+17.8%
+17.8%

More News

Read More
News headline image
ClearPoint Neuro Reports Second Quarter 2026 Results
From ClearPoint Neuro, Inc.
Via ACCESS Newswire
News headline image
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel
From ClearPoint Neuro, Inc.
Via ACCESS Newswire
News headline image
ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026
From ClearPoint Neuro, Inc.
Via ACCESS Newswire
ClearPoint Neuro Inc (NASDAQ:CLPT) Reports Q4 2025 Revenue Beat Amid Widened Loss, Shares Fall ↗
Via Chartmill
These stocks are moving in today's session ↗
Via Chartmill
Gapping stocks in Wednesday's session ↗
Via Chartmill
Discover the top movers in Wednesday's pre-market session. ↗
Via Chartmill
News headline image
ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint
Via ACCESS Newswire
News headline image
ClearPoint Neuro Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
ClearPoint (CLPT) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
ClearPoint Neuro Reports First Quarter 2026 Results
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint
Via ACCESS Newswire
News headline image
ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint
Via ACCESS Newswire
News headline image
ClearPoint Neuro (CLPT) Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results
Via ACCESS Newswire
News headline image
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026
Via ACCESS Newswire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Get insights into the top gainers and losers of Monday's pre-market session. ↗
Via Chartmill
News headline image
ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
Via ACCESS Newswire
News headline image
ClearPoint Neuro Completes Acquisition of IRRAS
Via ACCESS Newswire
News headline image
ClearPoint Neuro Reports Third Quarter 2025 Results
Via ACCESS Newswire

Frequently Asked Questions

Is ClearPoint Neuro Inc. - Common Stock publicly traded?
Yes, ClearPoint Neuro Inc. - Common Stock is publicly traded.
What exchange does ClearPoint Neuro Inc. - Common Stock trade on?
ClearPoint Neuro Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ClearPoint Neuro Inc. - Common Stock?
The ticker symbol for ClearPoint Neuro Inc. - Common Stock is CLPT on the Nasdaq Stock Market
What is the current price of ClearPoint Neuro Inc. - Common Stock?
The current price of ClearPoint Neuro Inc. - Common Stock is 12.40
When was ClearPoint Neuro Inc. - Common Stock last traded?
The last trade of ClearPoint Neuro Inc. - Common Stock was at 08/04/26 10:06 AM ET
What is the market capitalization of ClearPoint Neuro Inc. - Common Stock?
The market capitalization of ClearPoint Neuro Inc. - Common Stock is 293.14M
How many shares of ClearPoint Neuro Inc. - Common Stock are outstanding?
ClearPoint Neuro Inc. - Common Stock has 293M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.